Founder Suchismita Acharya calls the timing "perfect."
MORE►
Alcon Labs
From left, AyuVis Senior Research Scientist Sumita Behera with CEO and Founder Suchi Acharya. [Image: AyuVis]
Fort Worth Immunotherapy Startup Gets $1.8M Grant Ahead of First Clinical Trials
by Kevin Cummings | May 12, 2022
AyuVis, an immunotherapy startup, is set to get a $1.8 million Small Business Innovation Research grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funding will support the pre-clinical research of its drug candidate to treat the second-leading cause of death in premature babies.
Founder Suchismita Acharya calls the timing "perfect."
Founder Suchismita Acharya calls the timing "perfect."
